TP53 and lung carcinoma: YBX1 physically interacted with circRABL2B to decrease MUC5AC expression and affected integrin β4/pSrc/p53 axis, while knock-down of YBX1 counteracted the inhibitory effect of circRABL2B on lung cancer cells.